HIV researcher receives award nomination August 1, 2012 The Director of Murdoch University’s Institute for Immunology & Infectious Diseases has been named one of 11 finalists for the 2012 GlaxoSmithKline Award for Research Excellence (ARE). Professor Simon Mallal has been nominated for his research into genetic testing to prevent drug hypersensitivity. This work has led to significant advancements in both international HIV treatment guidelines and understanding drug toxicity. Professor Mallal said the nomination was an honour, especially as the jury consisted of previous ARE winners and leading Australian researchers. “It is always rewarding to be recognised by one’s peers, and with its long history, the GlaxoSmithKline Award for Research Excellence would be a feather in any researcher’s cap,” Professor Mallal said. “I look forward to the ceremony and extend my congratulations to all of my very worthy co-nominees. Their work is making a vital difference to health in Australia and the world.” As well as undertaking research at Murdoch University, Professor Mallal is a Consultant Clinical Immunologist at the Department of Clinical Immunology, Royal Perth Hospital, where he manages the care of patients with HIV, allergic and autoimmune diseases and provides immunopathology supervision of the routine laboratories. Now in its 32nd year, the ARE will be announced on September 11, 2012 at the Melbourne Museum. The award winner will receive an $80,000 research grant. Print This Post Media contact: Rob Payne Tel: (08) 9360-2491 | Mobile: | Email: firstname.lastname@example.org Categories: General, Teaching and Learning, Future Students, International students, Murdoch achievements, Experts Tags: drug toxicity, glaxosmithkline award for research excellence, hiv, institute for immunology and infectious diseases, melbourne museum, royal perth hospital, simon mallal Leave a comment Name (required) Mail (will not be published) (required) Website You can use these tags : <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong> We read every comment and will make every effort to approve each new comment within one working day. To ensure speedy posting, please keep your comments relevant to the topic of discussion, free of inappropriate language and in-line with the editorial integrity of this newsroom. If not, your comments may not be published. Thanks for commenting!